patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
trastuzumab
Marketedupdated 2mo agoby Genentech Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(3)
- Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and moreWelcome back to another edition of Endpoints Weekly! We’re doing a little bit of celebrating here at Endpoints, as we took home three Neal Awards, which recognize excellence in B2B journalism. The ...endpoints · 2mo ago
- Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs<p>On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.</p>biopharma_dive · 2mo ago
- Roche says its investigational breast cancer pill could outsell HerceptinRoche still has high sales hopes for its breast cancer pill giredestrant despite the drug’s failure in a first-line trial earlier this year. CEO Thomas Schinecker said Thursday that the drug coul…endpoints · 2mo ago
comments(0)
5-min edit window · permanent after that